IGF-I promotes growth during postnatal development via both endocrine and autocrine actions. In pcd mice (pcd/ pcd), we previously found that IGF-I mRNA expression was decreased in cerebellar Purkinje cells as they underwent apoptosis. To investigate the endocrine function of IGF-I, we examined hepatic IGF-I mRNA by Northern hybridization, circulating IGF-I peptide by radioimmunoassay, and circulating IGFBP by Western ligand blot in pcd mice. At postnatal days (D) 17 and 24, hepatic IGF-I mRNA and circulating IGF-I and IGF-II concentrations were normal in pcd mice. From D45, both hepatic IGF-I mRNA and circulating IGF-I concentrations decreased. The decrease in circulating IGF-I concentrations was accompanied by a simultaneous increase in circulating IGF-II concentrations in both the D45 and adult pcd mice. An early decrease in the circulating IGFBP-3 levels and an increase in the IGFBP-2 levels were observed at D17 and were followed by decreases in both IGFBPs at D45 and in the adult. Therefore, after the cerebellar neurodegeneration, there was an overall decrease in IGF-I gene expression in pcd mice. Our results suggest that the decrease in IGF-I gene expression may contribute to growth deficiency and multiple system degeneration in pcd mice.
Introduction
Insulin-like growth factor (IGF)-I is an important growth factor for postnatal development. It promotes metabolism and growth by both endocrine and autocrine/paracrine modes of action. The endocrine action of IGF-I is modulated via the classic hormone-regulating mechanism of the hypothalamus-pituitary-IGF axis. IGF-I is synthesized in the liver and released into the circulation under the control of pituitary growth hormone (GH), which is regulated by GH releasing hormone (GHRH) and somatostatin synthesized in the hypothalamus. Circulating IGF-I also exerts negative feedback at the pituitary and hypothalamus, to decrease GH and GHRH release, and increase somatostatin release. In addition, IGF-I is an autocrine/paracrine growth factor synthesized in many other tissues, including the brain.
The correlation between IGF system gene expression and postnatal brain growth is best illustrated in the cerebellum. During postnatal cerebellar development, IGF-I is expressed by Purkinje cells (Bondy et al. 1992) , the only projection neurons from the cerebellar cortex. Interestingly, gene expression of IGF-I is correlated with that of its receptor (IGFR-I) and two of the six high-affinity IGF binding proteins (IGFBPs), IGFBP-2 and -5, in different cell populations. Whereas IGFR-I is expressed by almost all cell types, IGFBP-2 is expressed by astroglia ) and IGFBP-5 by Golgi cells of the internal granular layer (IGL) and, transiently, by granule cell precursors in the external germinal layer (EGL) . The expression of these IGF system components is synchronized with Purkinje cell maturation, active synaptogenesis and dendritic growth, supporting an important functional role for IGF-I during the 'critical growth period' in the cerebellum (Davison & Dobbing 1968) .
We previously found that IGF-I mRNA expression was decreased when Purkinje cells underwent apoptosis in pcd mice (Zhang et al. 1996) . The pcd mutation is an autosomal recessive mutation on chromosome 13 (Mullen et al. 1976) , and pcd mice have multiple system degeneration, including the central nervous system and the reproductive system (Mullen et al. 1976) . The earliest pathological change is Purkinje cell degeneration, which occurs from postnatal day (D) 17 and leads to their almost complete depletion by adult life (Mullen et al. 1976) . At D24, when Purkinje cells start massive apoptosis, they express less IGF-I mRNA and less IGFR-I mRNA (Zhang et al. 1996) . Meanwhile, IGF-I gene expression is activated in the reactive astrocytes participating in the phagocytosis of Purkinje cell debris.
After the pathological changes in cerebellum, pcd mice show growth deficiency, with degeneration in multiple systems. The pcd mice are smaller than their wild-type littermates, with body weights of male pcd mice reduced to approximately 26% of normal by D26 (see below). In the central nervous system, in addition to the cerebellar neurons, mitral cells of the olfactory bulb, thalamic neurons, and photoreceptor cells of the retina also degenerate. In peripheral tissues, abnormal spermatogenesis is found in the testis (Mullen et al. 1976 ). All these cell populations that degenerate in pcd mice normally express the IGF-I gene or reside in close association with IGF-I-expressing cells. To date, the endocrine action of IGF-I in pcd mice has not been examined. Because the expression of mRNA for IGF-I, an important postnatal growth factor, is deficient in the pcd cerebellum, we hypothesize that gene expression of IGF-I as an endocrine growth factor is also deficient in pcd mice. Therefore, we measured IGF-I and IGF-II concentrations in the circulation by RIA, hepatic IGF-I mRNA concentrations by Northern blot hybridization, and circulating IGFBPs by Western ligand blot, during postnatal development and adulthood.
Materials and Methods

Animal and tissue preparation
The care and maintenance of the mice were in strict accordance with the NIH Guide for the Care and Use of Laboratory Animals. Animals were obtained from a colony of mice maintained at the Indiana University Medical Center, and originally established from pcd heterozygous (pcd/?) mice purchased from Jackson Laboratory (Bar Harbor, ME, USA). Wild-type (+/+) and mutant mice were maintained in a congenic C57BL/6J stock. Homozygous pcd mutants (pcd/pcd) were obtained by crossing pairs of heterozygous or homozygous females with heterozygous males. Food and water were available ad libitum, and the animals were subject to a 12 h light : 12 h darkness cycle. Mice were housed two per cage with the same genotype. Wet-feed was always provided to pcd mice, to help their feeding. As all tissues used were from male mice, body weights of five male +/+ mice and three pcd/pcd male mice were monitored from D26 to D46.
Four +/+ control mice and a litter of five pcd/? (pcd/pcd or pcd/?) from crossing pcd/pcd females and pcd/+ males were used at D17. At this age, although pcd/pcd mutants are difficult to differentiate from the pcd/+ mice, we would statistically expect 50% of the mice in this litter to be pcd/pcd mutants. Four wild type (+/+) and four to six homozygous (pcd/pcd) mice from each age group of D24, D45 and adult (3-5 months of age) mice were used and age-matched. Mice were decapitated and the serum and livers were immediately collected, frozen on dry ice and then stored at 70 C until required for use.
Radioimmunoassay
A formic acid-acetone extraction procedure was used to separate IGFs from IGFBPs (Bowsher et al. 1991) . Briefly, 30 µl plasma were added into 15 µl 0·8 M formic acid-0·5% Tween 20. Acetone (105 µl) was then added to precipitate the binding proteins. Each tube was vortexed and centrifuged for 15 min at 3000 g at 4 C. The supernatants were then diluted 1 : 20 with RIA buffer (50 mM Na 2 PO 4 , 0·1% NaCl, 0·1% EDTA, 0·1% NaN 3 , 0·02% protamine sulfate, 0·05% Tween-20, pH 7·5). The IGF-I and IGF-II concentrations in the serum samples were quantitated by polyclonal antibody-based RIA, using magnetic beads coated with a secondary antibody to separate bound and free IGF (Rinderknecht & Humbel 1978) . The supernatants from the extraction step were incubated with either 125 I-labeled recombinant human (rh) IGF-I or IGF-II and antibody (polyclonal rabbit anti-rhIGF-I kindly provided by Eli Lilly & Co., Indianapolis, IN, USA; monoclonal antibody against IGF-II was purchased from Amano International Enzyme Co., Troy, VA, USA). After incubation at room temperature for 20 h, the bound and free fractions were separated by precipitation with magnetic beads coated with a secondary antibody. The IGF concentrations were estimated from a standard curve of reference standard rhIGF-I or rhIGF-II. The radioactivity in the precipitates was measured in a gamma counter and the resulting data were analyzed by a weighted four-parameter logistic algorithm.
Western ligand blot
Mice serum samples (1·6 µl) were subjected to nonreducing discontinuous SDS-PAGE on a 4·0% stacking gel and 12% polyacrylamide separating gel for 45 min at 200 V. The proteins were transferred onto nitrocellulose membranes with a Bio-Rad transfer unit at 100 V for 1-1·5 h. The nitrocellulose membranes were washed with blocking buffer I (10 mM Tris, 150 mM NaCl, 0·05% NaN 3 , 0·1% BSA, 3% Nonidet P-40, pH 7·5) for 30 min. The membranes were then washed with blocking buffer II (10 mM Tris, 150 mM NaCl, 0·05% NaN 3 , 0·1% BSA, 0·1% Tween-20, pH 7·5) for 2 h and then rinsed in RIA buffer. The membranes were incubated with 1 µCi [ 125 I]IGF-II mixed in 5 ml RIA buffer at 4 C overnight. The membranes were then washed in RIA buffer and air-dried before exposure to radiographic film (Kodak) with intensifying screens at 70 C for 3 days. The Western ligand blot was repeated twice from the same tissue sample, and the results were reproducible. The identity of each of the IGFBPs was confirmed by blotting similar membranes with antibodies against different IGFBPs (Upstates Technology, Lake Placid, NY, USA). Unfortunately, the antibody made against recombinant human IGFBP-4 did not cross-react with that in mice.
RNA preparation
Total RNA was prepared by the RNAzol B method, modified from the acid guanidinium thiocyanate-phenolchloroform extraction method (Chomczynski & Sacchi 1987) . Briefly, 100 mg frozen liver was homogenized in 2 ml RNAzol B solution (Tel-Test Inc., Friendswood, TX, USA, Cat No. CS-105), vigorously mixed with 0·2 ml chloroform, cooled for 5 min on ice, and then centrifuged at 12 000 r.p.m. at 4 C. The aqueous layer was transferred to a new tube, mixed with an equal volume of isopropanol, stored at 4 C for 15 min, and then centrifuged at 12 000 r.p.m. for 15 min at 4 C. After centrifuging, the RNA pellet was washed in cold 75% ethanol and then dissolved in diethylpyrocarbonate-treated water, and stored at 80 C.
Northern blot hybridization
Total RNA (10 µg) was electrophoresed on a 1·2% agarose-formaldehyde gel at 20-25 V overnight. Photographs of the ethidium bromide-stained gel were taken under u.v. light. The quality and quantity of 18S and 28S were used to assess RNA integrity and evenness of loading. Separated RNA was transferred onto nitrocellulose membranes by capillary transfer in 20 SSC overnight, then cross-linked to the membranes by exposure to u.v. light. Membranes were prehybridized (50% formamide, 0·4 M Na 2 PO 4 , 1 mM EDTA, 5% SDS, and 1% BSA, pH 7·2) for 1-2 h at 42 C and then probed with a [ 32 P]cDNA probe (EcoRI and HindIII fragments isolated from rat IGF-I cDNA (Lowe et al. 1988) labeled with a Prime-It II Random Primer Labelling kit (Stratagene, La Jolla, CA, USA, Cat No. 300385)). The membranes were incubated at 42 C overnight, then washed sequentially in 2 SSC, 1% SDS, 0·1 SSC, 1 mM EDTA, and 0·5% SDS, all at room temperature.
Buffer used in the final two washes consisted of 0·1 SSC, 1 mM EDTA, and 0·5% SDS for 30 min at 70 C. The membranes were then air dried, exposed to radiographic film at 80 C for 2 weeks, and analyzed using scanning densitometry. The Northern blot hybridization was performed twice, starting from different RNA extractions of the same tissue sample, and the results were reproducible. Table 1 Body weights of +/+ and pcd/pcd male mice, at three postnatal dates. Body weights were measured at 0900 h every day for each mouse. The % decrease was calculated by subtracting the mean body weight of pcd/pcd mice from that of +/+ mice and dividing by the mean body weight of +/+ mice. Data are expressed as mean S.E.M. 
Body weight (g)
D26 D36 D46 Genotype +/+ (n=5) 12·19 0·33 19·03 0·17 21·76 0·39 pcd/pcd (n=3) 9·01 0·56 11·99 1·43 13·64 1·85 % decrease 26% 37% 37%
Image analysis and statistics
Autoradiographs were subjected to densitometric analysis (NIH Image 1·54). For each hepatic IGF-I mRNA species, the measurement of the optical density was obtained within a linear range by calibrating the exposure time for the autoradiographic films. The level of optic density was then corrected using the level of 18S rRNA in the same sample measured by the ethidium bromide stained agarose gel used for Northern blot. The mean and standard error of mean (...) were calculated and results were analyzed using two-way ANOVA and Student's t-test.
Results
General condition of the mice
At D17, the average weights, gross appearances and gaits of pcd/? mice were not appreciably different from those of the +/+ mice. After that, there was a gradual decrease in the body weights of pcd mice that was more apparent in male mice (Table 1 ). The body weights of male pcd/pcd mice decreased 26% by D26, and to 37% by D46, compared with +/+ mice (Table 1) . A mild ataxia of gait was already noticeable in pcd/pcd mutants at the time of weaning at D21, became distinctive by D24, and progressed to adulthood.
Figure 2
Northern blot hybridization analysis of the hepatic IGF-I mRNA in +/+, pcd/? and pcd/pcd mice at D17, D24, D45 and adult age. Total RNA prepared from +/+, pcd/? and pcd/pcd mice at D17 and D24 (A), and D45 and adult age (B) were analyzed for levels of hepatic mRNA for IGF-I and -actin. For each sample, three major bands of hepatic IGF-I mRNA (size 0·6-1·0 kb, 1·3 kb, and 7·5 kb) were detected. In order to show all the major hybridization bands of different sizes, we purposely overexposed the film. However, for quantitation purposes, we individualized the exposure time for each mRNA species to obtain optical density measurement within a linear range. In the lower panels, the quality and evenness of sample loading were shown by ethidium bromide staining of the 18S on the agarose gel used for the same Northern blot. The levels of all three IGF-I mRNA species were decreased at D45 and adult age in pcd/pcd mice compared with those of +/+ mice (Table 2) .
Circulating IGF-I and IGF-II concentrations
In +/+ mice, circulating IGF-I, but not IGF-II, concentrations varied with the developmental stage (P<0·01), as reported previously (Rechler & Nissley 1990) . In these mice, the average circulating IGF-I concentrations increased as the mice approached puberty, as shown at D45, and then declined towards adulthood (Fig. 1A) . In comparison, the average circulating IGF-I concentrations in the pcd mice did not show the surge associated with puberty at D45 (Fig. 1A) ; rather, they were 16% lower than those at D24, and declined further in adults (Fig. 1A) . In both strains of these mice, the IGF-II concentrations were higher at a younger age (D17), and decreased as the mice approached adulthood (Fig. 1B) . Both circulating concentrations of both IGF-I and -II were affected by the pcd mutation (P<0·05). The average circulating IGF-I concentrations in pcd/? mice at D17 or pcd/pcd mice at D24 did not differ from their age-matched +/+ controls (P>0·1). However, circulating IGF-I concentrations in pcd/pcd mice were decreased to 61 5% of those in their age-matched +/+ controls at D45 (P<0·01), and further decreased to 49 9% of normal in the adult pcd mice (P<0·01, Fig. 1A ). In contrast, the mean circulating IGF-II concentrations in D17 pcd/? mice or D24 pcd/pcd mice were similar to those of their age-matched +/+ controls (P>0·1), but increased to 212 33% (P<0·01) and to 143 19% (P<0·01) of their agematched +/+ controls at D45 and adult age respectively (Fig. 1B) .
Hepatic IGF-I mRNA levels
Northern blot hybridization revealed the presence of three major species of hepatic IGF-I mRNA, with the sizes of 0·6-1·0 kb, 1·3 kb, and 7·5 kb, in all the mice examined (Fig. 2) . Among these three species, the 0·6-1·0 kb mRNA was predominant. The level of each hepatic IGF-I mRNA was analyzed by measuring the optical density on film autoradiograph within a linear range and then normalized to the total RNA, estimated with reference to 18S rRNA (lower panels of Fig. 2A and B) . At D17 and D24, levels of all three species of IGF-I mRNA in +/+ mice were not significantly different from those in pcd/? mice ( Fig. 2A) . However, the levels of all three IGF-I mRNA species were significantly decreased in pcd/pcd mice at D45 and at adult age (Fig. 2B, Table 2 ). Overall, the decrease in pcd/pcd hepatic IGF-I mRNA was significantly greater (P<0·05 for all three IGF-I mRNA species) at D45 than the decrease in adult pcd/pcd mice.
Circulating IGFBP levels
Western ligand blot demonstrated the presence of IGFBPs-2, -3, and -4 in serum from both +/+ and pcd/pcd mice at different ages (Fig. 3A-D) . The molecular masses of these IGFBPs were confirmed with Western immunoblot and were approximately 32 (IGFBP-2) and 49 (IGFBP-3) kDa respectively (data not shown). The level of each IGFBP was measured as optical density on autoradiographic film, within a linear range; the comparison of these IGFBPs between +/+ and pcd/pcd mice is summarized in Table 3 and presented in Figs 3E and F.
Discussion
The pcd mouse presents a unique animal model in which to study the in vivo functions and regulation of IGF-I during postnatal development. The pcd mice develop normally before birth; afterwards, they develop multiple system degeneration, with the first sign of Purkinje cell death occurring around postnatal weeks 2-3 (Mullen et al. 1976) . At D24, we found a decreased IGF-I gene expression in the Purkinje cells as they underwent massive apoptosis, revealing a deficiency of IGF-I as an autocrine growth factor in the pcd cerebellum (Zhang et al. 1996) . After the early changes in the cerebellum, degeneration is also found in other areas that contain cells expressing high levels of IGF-I mRNA during postnatal development, such as the olfactory bulb, thalamus, retina, and testis (Mullen et al. 1976) . In this study, we found levels of both circulating IGF-I and hepatic IGF-I mRNA were decreased in pcd mice from at least D45. In addition, circulating IGFBPs were altered, starting at D17, and this alteration persisted into adult life. Our results demonstrate an overall decrease in IGF system gene expression as pcd mice develop neurological changes and growth retardation.
Because pcd mice are ataxic and have deficits in their visual and olfactory systems, they have difficulty with food intake, which results in nutritional deprivation and decreases in their body weight. In this study, we found a substantial decrease in body weight by D26 (26%) in male Table 2 Decrease in the three species of hepatic IGF-I mRNA at D45 and adulthood in pcd mice. Levels of mRNA were obtained by measuring the optical density of each band on autoradiographic film and corrected by the total RNA estimated by ethidium bromide staining of 18S on the agarose gel used for the same Northern blot. For each age group, the percentage decrease in mean mRNA levels for every mRNA species was calculated taking the level of the same mRNA species in +/+ mice as 100%. Values are mean S.E.M.
Decrease (%)
0·6-1·0 kb mRNA 1·3 kb mRNA 7·5 kb mRNA D45 53 5* 60 2* 59 7* Adult 37 5* † 15 6* † 40 9* † *Decreased compared with the same mRNA species in +/+ mice (P<0·05). †Decreased compared with the same mRNA species in D45 pcd/pcd mice (P<0·05).
pcd mice, and this decrease continued, to 37% by D46. Nutritional status is known to regulate the concentrations of circulating IGFs, such that diet restriction usually decreases the circulating concentrations of both IGF-I and IGF-II (Clemmons & Underwood 1991 , Thissen et al. 1994 , Rabkin 1997 , Duan 1998 . However, we found that the levels of both hepatic mRNA and circulating IGF-I were similar in pcd and wild-type mice at D24, when they demonstrated distinctive ataxias and reduced body weights. At D45, as the body weights of pcd mice continued to decrease, the levels of both hepatic IGF-I mRNA and circulating IGF-I ( 61%) showed a significant decrease. Interestingly, there was a simultaneous increase in circulating IGF-II concentrations at this age (D45), which was opposite to the changes in circulating IGF-I concentrations. Therefore, the increase in IGF-II concentrations, in addition to the lack of a parallel reduction in body weight and circulating IGF-I concentrations, indicated that hepatic IGF-I expression in pcd mice may not be regulated by nutritional status alone. The mechanisms that mediate the opposite change in concentration of circulating IGF-I and IGF-II in pcd mice are unclear. IGF-II shares a 62% amino acid sequence homology with IGF-I and has nearly equal affinity to IGFR-I (Rechler & Nissley 1990 ). However, IGF-II gene expression is regulated differently from that of IGF-I. IGF-II exhibits high levels of expression during embryogenesis (Bondy et al. 1990 ). Postnatally, IGF-II is synthesized in many tissues as a local growth factor, and its circulating concentrations are not controlled by GH (Daughaday & Rotwein 1989) . Therefore, IGF-II is considered primarily as an autocrine/paracrine growth factor after birth. To date, the pcd gene has not been identified, and the causes of pcd growth deficiency and multiple system degeneration are not known. Nonetheless, the opposite, but simultaneous, changes in circulating concentrations of IGF-I and IGF-II observed in pcd mice suggest that: (1) the effect of the pcd gene product on IGF-II gene expression was different than the effect on hepatic IGF-I; and (2) IGF-II might compensate for the activity of IGF-I in promoting growth and metabolism when the IGF-I concentration is low. However, the signal that mediates the decrease in IGF-I and the increase in IGF-II is not known, nor do we know which cell population increases synthesis of IGF-II in pcd mice. The mechanism of the increase in IGF-II concentrations needs to be further investigated.
In the circulation, IGF-I concentrations are regulated by GH, which is secreted by the somatotropes of the anterior pituitary and released into the circulation under the control of GHRH and somatostatin secreted from the hypothalamus (Hepler & Lund 1990) . Previous studies have shown that circulating concentrations of IGFBP-2 and -3 can reflect the status of GH, which regulates their production. For example, circulating IGFBP-3 concentrations decrease in patients with GH deficiency (Hintz et al. 1981 , Hardouin et al. 1989 and in hypophysectomized rats (Glasscock et al. 1991) , and are partially restored by infusion of GH (Hardouin et al. 1989 , Glasscock et al. 1991 . In contrast, circulating concentrations of IGFBP-2 are inversely related to GH status. IGFBP-2 concentrations increase in patients with hypopituitarism (Hintz et al. 1981 , Hardouin et al. 1989 . Hypophysectomy in rats increased IGFBP-2 concentrations, and this was reversed by GH administration (Zapf et al. 1989) . Although GH concentrations were not measured in our study because of limited samples, we observed a significant decrease in circulating IGFBP-3 concentrations and an increase in IGFBP-2 concentrations in the D17 pcd mice. This observation suggests that pcd mice lack the GH surge at the time of puberty that would occur in their normal littermates. The lack of GH surge is also supported by the fact that there is a larger decrease in the levels of both circulating IGF-I and hepatic IGF-I mRNA in D45 pcd mice than is observed in the adult pcd mice. As GH regulates the production and secretion of pubertal sex hormone, which also affects the increase in IGF-I (Murphy et al. 1987 , Buyalos 1995 , the deregulation of sex hormone in pcd mice would further decrease circulating concentrations of IGF-I. It is evident that further study of the concentrations of GH, GHRH, somatostatin and sex hormones in pcd mice is needed to confirm this speculation.
Overall, as an autocrine/paracrine growth factor, IGF-I mRNA exhibited decreased expression in the cerebellar Purkinje cells undergoing apoptosis at D24 in the pcd mice (Zhang et al. 1996) . Despite this cerebellar neurodegeneration and growth retardation during the first month after birth, the levels of both circulating IGF-I and hepatic IGF-I mRNA remain normal, indicating that Purkinje cells are selective targets of pcd gene product at this stage. Thereafter, as pcd mice develop growth retardation and multiple system deficiency, there is an alteration in circulating IGFs, IGFBPs and hepatic IGF-I mRNA. In addition, there is a lack of GH/IGF-I surge during puberty. The mechanisms that cause these alterations are complex and may involve other factors in addition to nutritional deficit. As the identity of the pcd gene product is currently unknown, it may be speculated that the cellular targets of the pcd gene product seem to be dependent on the developmental stage. These cells include those expressing the IGF-I gene, such as Purkinje cells during first month after birth and hepatocytes during the second month of life. Furthermore, the pcd gene product may interact with the regulatory mechanisms that normally control the transcription or translation of IGF system genes. As the identity of the pcd gene is revealed, we may gain insight into the regulation of IGF system genes in postnatal development, especially during puberty.
